insights_auto
Why is SDZNY up 2,14%?
Dive Deeperchevron_right
SDZNY:OTCMKTS
SANDOZ GROUP ADR
US$92,98
arrow_upward
+2,14%(+1,94) 1D
16 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZNY...
Open
US$92,15
High
US$93,52
Low
US$92,15
Mkt. cap
33,64 ຕື້
Avg. vol.
27,16 ພັນ
Volume
24,96 ພັນ
52-wk high
US$94,15
52-wk low
US$60,40
Shares outstanding
440,00 ລ້ານ
No. of employees
20 ພັນ
Open
US$92,15
High
US$93,52
Low
US$92,15
Mkt. cap
33,64 ຕື້
Avg. vol.
27,16 ພັນ
Volume
24,96 ພັນ
52-wk high
US$94,15
52-wk low
US$60,40
Shares outstanding
440,00 ລ້ານ
No. of employees
20 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
·
14 ຊົ່ວໂມງກ່ອນ
Sandoz stock: October 28 results are due for Sandoz stock
ad-hoc-news.de
·
22 ຊົ່ວໂມງກ່ອນ
Sandoz stock pre-market at EUR 81.94
ad-hoc-news.de
·
1 ມື້ກ່ອນ
Barclays keeps CHF 93.00 target for Sandoz stock
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About SANDOZ GROUP ADR
CEORichard Saynor
Employees20 ພັນ
Founded1886
Headquarters-
SectorPharmaceutical industry
Websitesandoz.com